The trial will investigate the accuracy of Dual Source CT coronary angiography to detect coronary artery stenoses in patients with chest pain who have, based on clinical criteria, an intermediate likelihood for the presence of coronary artery stenoses. No beta blockers will be used to lower the heart rate for the examination. The hypothesis is that Dual Source CT will allow the detection of vessels with at least one coronary artery stenosis with a sensitivity of more than 90%.
Study Type
OBSERVATIONAL
Enrollment
398
Vejle Medical Center
Vejle, Denmark
RECRUITINGUniversity of Erlangen
Erlangen, Germany
RECRUITINGRoentgenpraxis Hamburg
Hamburg, Germany
Accuracy for the detection of coronary artery stenoses
Invasive coronary angiography will be preformed within 72 hours to verify coronary CT angiography results.
Time frame: 72 hours
Safety of Ultravist 370 and Ultravist 300 for coronary CT angiography
Patients will be monitored for one hour after injection of Ultravist 370 and Ultravist 300 intravenously to assess safety and detect side effects.
Time frame: 1 hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Klinikum Grosshadern
Munich, Germany
NOT_YET_RECRUITINGDeutsches Herzzentrum Muenchen
München, Germany
RECRUITINGRavi Bathina
Hyderabad, India
RECRUITINGCardiovascular Institute
Monterrey, Mexico
RECRUITINGTan Tok Seng Hospital
Singapore, Singapore
RECRUITING